Form D — Indaptus Therapeutics, Inc.
0001493152-25-003248 · filed Jan 22, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $2,246,500
- Reported amount sold
- $2,246,500
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Indaptus Therapeutics, Inc.
- CIK
- 1857044
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 3 COLUMBUS CIRCLE
NEW YORK, NY 10019 - Phone
- (646) 427-2727
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
JEFFREY A. MECKLER · Executive OfficerNEW YORK, NY Find on LinkedIn ↗
-
WALT A LINSCOTT · Executive OfficerNEW YORK, NY Find on LinkedIn ↗
-
NIR SASSI · Executive OfficerNEW YORK, NY Find on LinkedIn ↗
-
MICHAEL J. NEWMAN · Executive OfficerNEW YORK, NY Find on LinkedIn ↗
-
ROGER WALTZMAN · Executive OfficerNEW YORK, NY Find on LinkedIn ↗
-
HILA KARAH · DirectorNEW YORK, NY Find on LinkedIn ↗
-
ANTHONY J. MADDALUNA · DirectorNEW YORK, NY Find on LinkedIn ↗
-
WILLIAM B. HAYES · DirectorNEW YORK, NY Find on LinkedIn ↗
-
ROGER J. POMERANTZ · DirectorNEW YORK, NY Find on LinkedIn ↗
-
MARK J GILBERT · DirectorNEW YORK, NY Find on LinkedIn ↗
-
ROBERT E. MARTELL · DirectorNEW YORK, NY Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗